COVID-19 infection after recent heart transplantation: a case report
https://doi.org/10.15829/1560-4071-2020-3904
Abstract
History of heart transplantation in combination with immunosuppressive therapy and acute viral respiratory infection overlay makes the patient difficult to manage. In case of COVID-19, the setting is complicated by unknown pathogenesis, including its effect on blood, coagulation system, and lung tissue. Current case report discusses the 60-year-old patient with a COVID-19 infection occurred in the immediate postoperative period after heart transplantation.
About the Authors
V. I. Vechorko
O. M. Filatov City Clinical Hospital № 15; Pirogov Russian National Research Medical University
Russian Federation
Moscow
Competing Interests: not
Russian Federation
Moscow
Competing Interests: not
I. G. Gordeev
Pirogov Russian National Research Medical University
Moscow
Competing Interests: not
Moscow
Competing Interests: not
E. V. Gubareva
O. M. Filatov City Clinical Hospital № 15
Russian Federation
Moscow
Competing Interests: not
Russian Federation
Moscow
Competing Interests: not
E. V. Ryndyaeva
O. M. Filatov City Clinical Hospital № 15
Moscow
Competing Interests: not
Moscow
Competing Interests: not
O. V. Averkov
O. M. Filatov City Clinical Hospital № 15; Pirogov Russian National Research Medical University
Russian Federation
Moscow
Competing Interests: not
Russian Federation
Moscow
Competing Interests: not
References
1. Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter. Am J Transplant. 2020. doi:10.1111/ajt.15941.
2. DeFilippis EM, Farr MA, Givertz MM. Challenges in Heart Transplantation in the Era of COVID-19. Circulation. 2020. doi:10.1161/circulationaha.120.047096.
3. Li F, Cai J, Dong N. First cases of COVID-19 in heart transplantation from China. J Heart Lung Transplant. 2020;39 (5):496-7. doi:10.1016/j.healun.2020.03.006.
4. Holzhauser L, Lourenco L, Sarswat N, et al. Early Experience of COVID-19 in Two Heart Transplant Recipients: Case Reports and Review of Treatment Options. Am J Transplant. 2020. doi:10.1111/ajt.15982.
5. Ren ZL, Hu R, Wang ZW, et al. Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report. J Heart Lung Transplant. 2020;39 (5):412-7. doi:10.1016/j.healun.2020.03.008.
6. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi:10.1016/j.jcv.2020.104362.
7. Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. J Thromb Haemost. 2020. doi:10.1111/jth.14850.
8. Buy MZ, Lebedeva AY, Gordeev IG, et al. Heart rate variability and hemostatic parameters in patients with coronary heart disease and chronic heart failure. Russ J Cardiol. 2013;(5):6-11. (In Russ.) doi:10.15829/1560-4071-2013-5-6-11.
9. Canonico ME, Siciliano R, Scudiero F, et al. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19. Eur Heart J Cardiovasc Pharmacother. 2020. doi:10.1093/ehjcvp/pvaa048.
10. Bokarev I, Lusov V, Kirienko A, et al. Venous Thrombosis and Pulmonary Thromboembolism. Russ J Cardiol. 2011; (4):5-12. (In Russ.)
11. Taratukhin EO. Risk factros hierarchy. Russ J Cardiol. 2017;22(9):28-33. (In Russ.) doi:10.15829/1560-4071-2017-9-28-33.
Review
For citations:
Vechorko V.I., Gordeev I.G., Gubareva E.V., Ryndyaeva E.V., Averkov O.V. COVID-19 infection after recent heart transplantation: a case report. Russian Journal of Cardiology. 2020;25(5):3904. https://doi.org/10.15829/1560-4071-2020-3904
Views:
1427
Email this article 